Based on community reports: What users commonly report: Reduced inflammation and redness (24 weeks) Slower lesion progression Improved healing of cracked/bleeding plaques Better response to other treatments when stacked What peptides likely won't do: Completely clear severe psoriasis Replace biologics for moderate-to-severe cases Work immediately (expect 48 week timeline) Protocol Considerations Starting a Peptide Protocol for Psoriasis Get a baseline: Document current lesion coverage (photos, PASI score if available) Start with one peptide: GHK-Cu or BPC-157 alone for 24 weeks Add sequentially: This lets you identify what's helping Track consistently: Weekly photos, symptom diary Sample Stack (Not Medical Advice) Conservative approach: GHK-Cu 1 mg subQ daily (skin repair focus) BPC-157 250 mcg subQ daily (anti-inflammatory) Duration: 8 weeks, then reassess More aggressive approach (for those comfortable with peptides): KLOW blend per dosing guide (covers BPC/TB/GHK) Add KPV 200 mcg if available (NF-B focus) Duration: 812 weeks Complementary Strategies Peptides work best alongside foundational approaches: Diet: Anti-inflammatory diet, reduce processed foods Vitamin D: Optimize levels (psoriasis has strong Vitamin D connection) Omega-3s: High-dose fish oil (24g EPA/DHA) Stress management: Psoriasis flares with cortisol Topicals: Continue prescribed treatments Frequently Asked Questions Q: Can I use peptides while on biologics (Humira, Skyrizi, etc.)

SUPERIOR TO NMN & NR: Superior to nicotinamide riboside at increasing NAD Plus throughout the body, including the muscles and brain
CYP2R1 expression was not seen in FL83B mouse hepatocytes) and 1--hydroxylase (CYP27B1), along with the increased expression of 24-hydroxylase (CYP24A1), was observed in GSH-deficient hepatocytes
Temporary increase in fine lines during weeks two through six can reflect normal collagen remodeling
Safety, Stability, and Storage This copper peptide has a favorable safety profile across decades of research
Considering the multiple effects of this powerful antioxidant agent and its interactions with cancer cells and anticancer treatments, further studies are certainly needed to define once and for all its role for cancer patients